Nantahala Capital Management - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 279 filers reported holding CYTOKINETICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q3 2023$5,280,911
-9.7%
179,2570.0%0.45%
-20.2%
Q2 2023$5,847,363
+453.9%
179,257
+497.5%
0.56%
+597.5%
Q1 2023$1,055,700
+379.8%
30,000
+524.7%
0.08%
+478.6%
Q4 2022$220,0284,8020.01%
Other shareholders
CYTOKINETICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 223,382$6,580,8347.72%
Finepoint Capital LP 431,693$12,717,6766.33%
Saturn V Capital Management LP 495,168$14,587,6496.11%
Logos Global Management LP 1,250,000$36,825,0004.91%
DAFNA Capital Management LLC 479,538$14,127,1894.39%
PFM Health Sciences, LP 2,399,545$70,690,5963.33%
Boxer Capital, LLC 2,100,000$61,866,0003.29%
Integral Health Asset Management, LLC 800,000$23,568,0003.26%
GREAT POINT PARTNERS LLC 600,000$17,676,0003.22%
Nicholas Investment Partners, LP 942,137$27,755,3562.07%
View complete list of CYTOKINETICS INC shareholders